Additionally, the number of patients diagnosed with high risk disease with an elevated risk of metastasis and death is still considerable, and an increasing trend has been described [ 3 , 4 ].
← all excerpts
Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics.
1
—
—